Table 2.
Association of LCN2 expression with the features of OSCC patients.
| Characteristics | LCN2 expression | P value | |
|---|---|---|---|
| High (%) | Low (%) | ||
| Age | |||
| ≤40 | 11 (42.31) | 15 (57.69) | |
| >40 | 13 (33.33) | 26 (66.67) | 0.4705 |
| Gender | |||
| Male | 14 (36.84) | 24 (63.16) | |
| Female | 10 (37.04) | 17 (62.96) | 0.9874 |
| Differentiation | |||
| Well | 6 (22.22) | 21 (77.78) | |
| Moderate | 8 (36.36) | 14 (63.64) | |
| Poor | 10 (62.50) | 6 (37.50) | 0.0087 |
| Lymphatic metastasis | |||
| No | 7 (21.88) | 25 (78.12) | |
| Yes | 17 (51.52) | 16 (48.48) | 0.0128 |
| Clinical stage (T) | |||
| 1 | 2 (11.76) | 15 (88.24) | |
| 2 | 9 (40.91) | 13 (59.09) | |
| 3 | 8 (50.00) | 8 (50.00) | |
| 4 | 5 (50.00) | 5 (50.00) | 0.0233 |
Lcn2 positive 24 (36.92%), negative 41 (63.08%)